Black Diamond Therapeutics, Inc. - Common Stock (BDTX)

CUSIP: 09203E105

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+1,310,200
Put/Call ratio
17%
SEC-reported price per share
$5.07
Number of holders
86
Value change
+$10,671,909
Number of buys
49
Open additional details 1 more signal available
Number of sells
36
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
57,292,388

Security key

09203E105

Report period

Q1 2024

Institutions

86

Top holders

10

Ownership snapshot

Top reported holders of BDTX - Black Diamond Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bradley J. Bolzon PhD
Disclosed value leader
Bellevue Group AG
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5 13F Highest disclosed value: $23,985,708 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bellevue Group AG has the largest disclosed position value at $23.99M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bellevue Group AG's linked filing trail.
Disclosed position value Top 5
Bellevue Group AG $23.99M
NEA Management Company, LLC $12.5M
T. Rowe Price Investment Manageme... $11.04M
RA CAPITAL MANAGEMENT, L.P. $9.91M
Artal Group S.A. $5.75M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bradley J. Bolzon PhD
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
15,000 shares
— 18 Jun 2021
Bellevue Group AG
13F
Company
13F
—
denominator unverified
$23,985,708
8,535,839 shares
— 31 Dec 2023
NEA Management Company, LLC
13F
Company
13F
—
denominator unverified
$12,501,007
4,448,757 shares
— 31 Dec 2023
T. Rowe Price Investment Management, Inc.
13F
Company
13F
—
denominator unverified
$11,038,000
3,927,879 shares
— 31 Dec 2023
RA CAPITAL MANAGEMENT, L.P.
13F 3/4/5
Company · Director
—
denominator unverified
$9,907,369
3,525,754 shares
— 31 Dec 2023
Artal Group S.A.
13F
Company
13F
—
denominator unverified
$5,751,000
2,046,517 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
86
Shares
39,430,252
Rows available
86
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
86
Q1 2024 holders
86
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .